DiscoveRx Corporation
DiscoveRx is a fast growing innovative company that develops, manufactures, and commercializes reagents and complete assay kits for the drug discovery and screening markets. Our products, which include both in vitro biochemical assays and cell-based assays, enable customers to improve research productivity and effectiveness, thus accelerating the discovery and development of new drugs.
Reviews
- Ease of use
- After sales service
- Value for money
"'"
Kathyrn Woods
‘Membership Status’ indicates whether this member is an active reviewer on the site, and how many reviews have been published.| Status: | No. Reviews Published: |
| Member | 0 |
Reviewer | 1-4 |
| Advanced Reviewer | 5-14 |
| Expert Reviewer | 15+ |
To be seen as an authority on SelectScience, find your products to review today., Pfizer
Latest Videos
Latest news
News
DiscoveRx to Launch PathHunter™ GPCR Explorer Kit for Building On-Demand Functional GPCR Assays at MipTec 2010
15 Sep 2010
-
DiscoveRx Announces 35% Off Whole Panel Profiling Orders
22 Jan 2010
-
DiscoveRx Signs a Worldwide Agreement with GlaxoSmithKline (GSK) that Allows GSK Access to PathHunter™ ß-Arrestin Cell lines and Reagents for G-PCR Screening
29 Oct 2009
-
DiscoveRx PathHunter™ eXpress Kits and GPCR Profiling Services: GPCR Research Made Simple
12 Sep 2008
-
High Sensitivity ADP Accumulation Assays for Kinases and ATPases
08 May 2007
Application articles
-
Automating a Direct, Cell-Based, Target-Compound Interaction Assay for G9a Histone Methyltransferase and Bromodomain Proteins
DiscoveRx Corporation16 Apr 2013
-
InCELL Hunter: A Novel Cellular Assay Platform for the Direct Measurement of Compound Binding to Epigenetic and Kinase Targets in Intact Mammalian Cells
DiscoveRx Corporation24 Sep 2012
-
High Throughput, Quantitative Ligand Binding Assays for Human Bromodomains
DiscoveRx Corporation07 Mar 2012
-
Exploring & Exploiting Allosteric Inhibitors & Covalent Inhibitors
DiscoveRx Corporation29 Jun 2011
-
Rapid Quantification of Bioactive Ligands in Serum and Human Plasma Using PathHunter eXpress β-Arrestin GPCR Assays
DiscoveRx Corporation18 May 2011
